持股变动声明
Rani Therapeutics(RANI)03-23 09:05
$Rani Therapeutics(RANI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-035572 Size: 5 KB 网页链接
简介:Rani Therapeutics Holdings, Inc.于2021年4月6日在特拉华州注册成立。他们是一家临床阶段的生物治疗公司,推进技术以促进口服生物制剂的开发,他们认为这有可能改变医学并改善患者的治疗效果。他们开发了 RaniPill 胶囊,这是他们新颖的、专有的和专利的平台技术,旨在用口服给药代替皮下或静脉注射生物制剂。
今开:3.9 | 昨收:3.89 |
最高:4.2052 | 最低:3.9 |
涨停价: | 跌停价: |
总市值:201681260 |
Rani Therapeutics(RANI)03-23 09:05
$Rani Therapeutics(RANI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-035572 Size: 5 KB 网页链接
Rani Therapeutics(RANI)03-23 09:05
$Rani Therapeutics(RANI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-035570 Size: 5 KB 网页链接
Rani Therapeutics(RANI)05-07 04:15
$Rani Therapeutics(RANI)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-053527 Act: 34 Size: 348 KB 网页链接
Rani Therapeutics(RANI)05-07 04:15
$Rani Therapeutics(RANI)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-053548 Act: 34 Size: 7 MB 网页链接
Rani Therapeutics(RANI)05-31 04:15
$Rani Therapeutics(RANI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-066586 Size: 5 KB 网页链接
Rani Therapeutics(RANI)03-23 09:05
$Rani Therapeutics(RANI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-035571 Size: 5 KB 网页链接
Rani Therapeutics(RANI)03-23 09:35
$Rani Therapeutics(RANI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-035576 Size: 5 KB 网页链接
Rani Therapeutics(RANI)05-31 04:05
$Rani Therapeutics(RANI)$ 8-K Current report, item 5.07 Accession Number: 0000950170-24-066552 Act: 34 Size: 172 KB 网页链接
Rani Therapeutics(RANI)03-23 09:05
$Rani Therapeutics(RANI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-035573 Size: 5 KB 网页链接
Rani Therapeutics(RANI)04-17 20:05
$Rani Therapeutics(RANI)$ ARS Annual Report to Security Holders Accession Number: 0001140361-24-020201 Act: 34 Size: 1 MB 网页链接
真是个苏呆子2023-06-26 14:27
口服基本是凉了,Rani这笔投资估计收不回来了$长春高新(SZ000661)$查看全文
真是个苏呆子2022-12-02 17:40
回复@zhangsan2019: 倒也未必,Rani在美股有上市的,就是市值很小很小$Rani Therapeutics(RANI)$ $长春高新(SZ000661)$//@zhangsan2019:回复@真是个苏呆子:不用说打水漂了查看全文
老李要努力2022-11-29 11:39
$长春高新(SZ000661)$ RT-109
Following a strategic priority review, Rani has decided not to continue active development of RT-109, a RaniPill capsule containing human growth hormone. Rani remains open to partnering opportunities with respect to RT-109, but intends to focus...查看全文
火火火球2022-11-28 23:23
$长春高新(SZ000661)$ 1、安沃高新3年多迟迟不能投产,理由是疫情影响,为何理由牵强?2、Rani口服合作终止,理由是样品运输问题,为何不在国内尝试口服?总之,是个潜在的雷了。查看全文
摇摇晃晃小老虎2022-08-29 11:25
回复@薪火相传-百年成长: 刚看到,多谢!这么看今年Rani的口服生长激素就一期了,加上多方面信息,这个生长激素用药就是长高生产,所以相当于长高口服生长激素在美国一期了$长春高新(SZ000661)$//@薪火相传-百年成长:回复@摇摇晃晃小老虎: 查看图片查看全文
真是个苏呆子2022-08-28 10:54
回复@摇摇晃晃小老虎: 这个信息很有价值$长春高新(SZ000661)$//@摇摇晃晃小老虎:回复@真是个苏呆子:对了,既然谈到口服生长激素的问题,在此补充一点Rani的最新消息:2022年8月10日,Rani完成了口服药丸载甲状旁腺素(一种用以治疗骨质疏松的激素)临床试验的结果,展示出好于针剂300-400%...查看全文
稷下小鱼2022-08-21 11:45
2022 年 8 月 21 日,未来科学大奖揭晓,其中,“生命科学奖”授予北京生命科学研究所、清华大学生物医学交叉研究院网页链接查看全文
2021年8月5日,制药公司Rani Therapeutics(股票代码:RANI.US,下文简称Rani)在纳斯达克完成首次公开募股(IPO),股价起价为每股11美元,共发行670万股,募资总额为7330万美元。该公司最初的目标是进行价值约1亿美元的IPO,6月30日股价在14... 网页链接
同花顺(300033)金融研究中心8月4日讯,有投资者向长春高新(000661)提问, 董秘你好,请问一下公司当初1500万美元投资美国rani公司,占比1.2%,可当下rani公司市值2亿美元,相对于前期投资有较大亏损,公司有考虑进一步投资甚至收... 网页链接
$Rani Therapeutics(RANI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-066722 Size: 5 KB 网页链接
$Rani Therapeutics(RANI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-066578 Size: 5 KB 网页链接
$Rani Therapeutics(RANI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-066580 Size: 5 KB 网页链接
$Rani Therapeutics(RANI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-066579 Size: 5 KB 网页链接
$Rani Therapeutics(RANI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-066586 Size: 5 KB 网页链接
$Rani Therapeutics(RANI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-066581 Size: 5 KB 网页链接
$Rani Therapeutics(RANI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-066582 Size: 5 KB 网页链接
$Rani Therapeutics(RANI)$ 8-K Current report, item 5.07 Accession Number: 0000950170-24-066552 Act: 34 Size: 172 KB 网页链接
$Rani Therapeutics(RANI)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-053527 Act: 34 Size: 348 KB 网页链接
$Rani Therapeutics(RANI)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-053548 Act: 34 Size: 7 MB 网页链接